Deals

Marathon Partners pushes Dr. Martens for strategic review, possible sale

02 April 2024, 11:40 am 1 minute

Reuters exclusively reported that investment firm Marathon Partners Equity Management wants British boot maker Dr. Martens to hire bankers and begin an immediate strategic review that could lead to a sale of the company.

Market Impact

Marathon Partners argues Dr. Martens’ stalled earnings growth and sharp share price drop of 83% since its public listing in 2021 have decoupled its valuation from its intrinsic value.

Article Tags

Topics of Interest: Deals

Type: Reuters Best

Sectors: Business & Finance

Regions: Europe

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Important Regional Story

Share this article

Work Email Address *

Country *

I'd like to receive communications about Reuters resources, events, products, or services.

(Please note you can manage and update your preferences at any time.) By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement.

By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement. * required field

Work Email Address *

Country *

More of Reuters Best

Abu Dhabi’s largest Islamic bank in talks to buy $1.1 bln stake in Indonesian lender

Marathon Partners pushes Dr. Martens for strategic review, possible sale

Market Impact

More of Reuters Best

Abu Dhabi’s largest Islamic bank in talks to buy $1.1 bln stake in Indonesian lender

Billing software firm Zuora explores sale after takeover interest

Vietnam mounts ‘unprecedented’ $24 billion rescue for bank engulfed in giant fraud

Lockheed wins US missile defense contract worth $17 bln